Trial NCT04314843

View at ClinicalTrials.gov 
Org. Study IDs: KT-US-471-0119
Secondary IDs: 2019-004568-23

Last trial update was posted on 2024-03-04

MeSH Interventions

Axicabtagene ciloleucel Cyclophosphamide Fludarabine Lenzilumab

MeSH Conditions

Lymphoma Lymphoma, B-Cell

Other Conditions

Relapsed/Refractory Large B-cell Lymphoma

Stopping Reasons

Development program terminated and the decision was not due to any safety concerns.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID